©The Author(s) 2025.
World J Gastrointest Surg. Dec 27, 2025; 17(12): 113940
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.113940
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.113940
Table 6 Univariate and multivariate analysis of prognostic factors for recurrence-free survival in first recurrence data
| Variable | Before PS matching (n = 36) | After PS matching (n = 32) | ||||||
| Univariate | Multivariate | Univariate | Multivariate | |||||
| HR (95%CI) | P value | HR (95%CI) | P value | HR (95%CI) | P value | HR (95%CI) | P value | |
| Treatment | 0.32 (0.13-0.81) | 0.016 | 0.29 (0.09-0.97) | 0.043 | 0.39 (0.15-1.00) | 0.051 | 0.46 (0.13-1.61) | 0.226 |
| Age | 0.99 (0.95-1.03) | 0.586 | 1.00 (0.96-1.05) | 0.847 | ||||
| Gender | 2.77 (0.97-7.95) | 0.058 | 6.60 (1.79-24.32) | 0.004 | 3.22 (1.12-9.28) | 0.030 | 6.81 (1.98-23.41) | 0.002 |
| HBV | 0.61 (0.25-1.47) | 0.267 | 0.74 (0.30-1.82) | 0.508 | ||||
| HCV | 1.04 (0.40-2.72) | 0.937 | 0.88 (0.33-2.33) | 0.795 | ||||
| ICG-R15 < 10% | 1.22 (0.48-3.07) | 0.675 | 2.42 (0.88-6.66) | 0.088 | 1.33 (0.37-4.84) | 0.660 | ||
| Platelet | 0.99 (0.99-1.00) | 0.137 | 0.99 (0.98-1.00) | 0.129 | 1.00 (0.99-1.00) | 0.321 | ||
| Prothrombin time | 1.35 (0.95-1.92) | 0.098 | 1.21 (0.88-1.66) | 0.235 | 1.29 (0.90-1.87) | 0.167 | 1.28 (0.91-1.80) | 0.153 |
| AST | 1.00 (1.00-1.00) | 0.418 | 1.00 (1.00-1.00) | 0.672 | ||||
| ALT | 1.00 (1.00-1.00) | 0.74 | 1.00 (1.00-1.00) | 0.782 | ||||
| AFP ≥ 100 ng/mL | 2.09 (0.82-5.32) | 0.12 | 2.60 (0.72-9.44) | 0.145 | 2.69 (1.04-6.97) | 0.041 | 2.08 (0.54-8.01) | 0.285 |
| Bilirubin total | 1.72 (0.63-4.70) | 0.293 | 1.26 (0.43-3.70) | 0.675 | ||||
| Albumin | 0.69 (0.24-1.98) | 0.491 | 0.63 (0.23-1.73) | 0.369 | ||||
| ALBI | 1.44 (0.52-3.97) | 0.482 | 1.28 (0.42-3.88) | 0.66 | ||||
| Child-Pugh | 1.32 (0.38-4.53) | 0.658 | 1.15 (0.33-3.98) | 0.824 | ||||
| T stage | 1.36 (0.60-3.08) | 0.455 | 1.34 (0.59-3.04) | 0.482 | ||||
| Major tumor size | 1.01 (0.67-1.53) | 0.951 | 1.08 (0.68-1.71) | 0.743 | ||||
| Aggregate tumor size | 1.08 (0.89-1.32) | 0.436 | 1.12 (0.93-1.35) | 0.214 | ||||
| Tumor numbers | 1.30 (0.85-1.98) | 0.224 | 1.30 (0.87-1.95) | 0.202 | ||||
| BCLC | 1.08 (0.50-2.31) | 0.843 | 1.41 (0.64-3.14) | 0.397 | ||||
| SAS | 0.74 (0.29-1.85) | 0.514 | 1.02 (0.40-2.60) | 0.967 | ||||
| Complication | 4.20 (1.65-10.70) | 0.003 | 3.62 (1.09-11.96) | 0.034 | 3.78 (1.46-9.75) | 0.006 | 3.08 (0.76-12.44) | 0.114 |
- Citation: Peng CM, Lin SC, Cheng YY, Cheng TC, Hsieh CL, Hsieh CH, Hsieh MF, Liao CH, Liu MC, Liu YJ. Outcomes of robotic liver resection and intraoperative radiofrequency ablation for hepatocellular carcinoma in posterior segments VII and VIII. World J Gastrointest Surg 2025; 17(12): 113940
- URL: https://www.wjgnet.com/1948-9366/full/v17/i12/113940.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i12.113940